Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
  Overview | Kerydin | AN2718 | AN2728 | AN2898 | AN3365 | Animal Health | Neglected Diseases | Clinical Trials
    Pipeline - 2690

We believe the unique characteristics of boron allow us to engineer novel product candidates that target a broad range of diseases and drive a rapid and efficient drug development process. Learn more about Kerydin
Learn more about AN2728



 

Kerydin™ (tavaborole) topical solution, 5% has received FDA approval. Please click here for prescribing information.

To report an Adverse Event or Product Complaint associated with Kerydin
Please call 1-844-4ANACOR (1-844-426-2267), select option 1
Or
Email drugsafety@anacor.com

To request Medical or Drug Information about Kerydin
Please call 1-855-260-3479
or
Email FougeraPCC@druginfo.com

To reach Customer Service for Kerydin
Please call 1-800-525-8747
or
Email customerservice@pharmaderm.com

 

spacer